Potassium Citrate
- Product NDC
- 42291-500
- 11-digit product format
- 422910500
- Labeler code
- 42291
- Product ID
- 42291-500_d57d2f2c-af16-c5ac-e053-2995a90ae39f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Potassium Citrate
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- AvKARE
- Application
- ANDA212779
- Marketing category
- ANDA
- Marketing start
- 2020-11-18
- Marketing end
- 0000-00-00
- Substance
- POTASSIUM CITRATE
- Active strength
- 15 meq/1
- Pharmacologic classes
- Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 42291-500-01 | 42291050001 | 100 TABLET, EXTENDED RELEASE in 1 BOTTLE (42291-500-01) | 2020-11-18 | 0000-00-00 | No | No | Current |